Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Specialties
Publications
Articles from Nancy Dvorin:
Read all from this author
Perspective & Commentary

Digital Edition: MedTech Strategist June 2026

  • 2026-06-01 00:00:00.0
  • Nancy Dvorin
  • MedTech Strategist

Medtronic aims to prove that RDN can do more than lower blood pressure; NVIDIA's David Niewolny on supplying medtechs with computational powers that enable them to build out surgical AI; New approaches for AAAs; Stryker buys Amplitude Vascular to grow peripheral vascular division; from Market Pathways: should generative AI tools be trained, evaluated, and monitored like doctors as an alternative to regulatory oversight? Plus profiles of Entirety Biomedical and Urologic Health.

Read Article